Alcon Inc. (ALC)

Market Cap	43.74B
Revenue (ttm)	9.91B
Net Income (ttm)	1.02B
Shares Out	494.62M
EPS (ttm)	2.05
PE Ratio	42.97
Forward PE	27.10
Dividend	$0.26 (0.30%)
Ex-Dividend Date	May 14, 2024

Volume	870,081
Open	87.56
Previous Close	86.81
Day's Range	87.34 - 89.08
52-Week Range	77.54 - 101.10
Beta	0.83
Analysts	Strong Buy
Price Target	103.10 (+15.9%)
Earnings Date	May 12, 2025

About ALC

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,599
• Stock Exchange: NYSE
• Ticker Symbol: ALC
• Website: https://www.alcon.com

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Analyst Forecast

According to 12 analysts, the average rating for ALC stock is "Strong Buy." The 12-month stock price forecast is $103.1, which is an increase of 15.90% from the latest price.

Price Target

$103.1

(15.90% upside)

Analyst Consensus: Strong Buy